Literature DB >> 32291285

The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.

Abdul A Waheed1, Maya Swiderski2, Ali Khan2, Ariana Gitzen2, Ahlam Majadly2, Eric O Freed2.   

Abstract

Host proteins with antiviral activity have evolved as first-line defenses to suppress viral replication. The HIV-1 accessory protein viral protein U (Vpu) enhances release of the virus from host cells by down-regulating the cell-surface expression of the host restriction factor tetherin. However, the exact mechanism of Vpu-mediated suppression of antiviral host responses is unclear. To further understand the role of host proteins in Vpu's function, here we carried out yeast two-hybrid screening and identified the V0 subunit C of vacuolar ATPase (ATP6V0C) as a Vpu-binding protein. To examine the role of ATP6V0C in Vpu-mediated tetherin degradation and HIV-1 release, we knocked down ATP6V0C expression in HeLa cells and observed that ATP6V0C depletion impairs Vpu-mediated tetherin degradation, resulting in defective HIV-1 release. We also observed that ATP6V0C overexpression stabilizes tetherin expression. This stabilization effect was specific to ATP6V0C, as overexpression of another subunit of the vacuolar ATPase, ATP6V0C″, had no effect on tetherin expression. ATP6V0C overexpression did not stabilize CD4, another target of Vpu-mediated degradation. Immunofluorescence localization experiments revealed that the ATP6V0C-stabilized tetherin is sequestered in a CD63- and lysosome-associated membrane protein 1 (LAMP1)-positive intracellular compartment. These results indicate that the Vpu-interacting protein ATP6V0C plays a role in down-regulating cell-surface expression of tetherin and thereby contributes to HIV-1 assembly and release.

Entities:  

Keywords:  ATP6V0C; HIV restriction factor; Western blot; host-pathogen interaction; human immunodeficiency virus (HIV); immunohistochemistry; innate immunity; lysosome; protein interactions; tetherin; vacuolar ATPase; viral protein U (Vpu); virus assembly; virus release

Mesh:

Substances:

Year:  2020        PMID: 32291285      PMCID: PMC7247306          DOI: 10.1074/jbc.RA120.013280

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  104 in total

1.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  The pericentriolar recycling endosome plays a key role in Vpu-mediated enhancement of HIV-1 particle release.

Authors:  Vasundhara Varthakavi; Rita M Smith; Kenneth L Martin; Aaron Derdowski; Lynne A Lapierre; James R Goldenring; Paul Spearman
Journal:  Traffic       Date:  2006-03       Impact factor: 6.215

3.  Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.

Authors:  Marie Lambelé; Herwig Koppensteiner; Menelaos Symeonides; Nathan H Roy; Jany Chan; Michael Schindler; Markus Thali
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

4.  Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes.

Authors:  Robert Grützmann; Hinnerk Boriss; Ole Ammerpohl; Jutta Lüttges; Holger Kalthoff; Hans Konrad Schackert; Günter Klöppel; Hans Detlev Saeger; Christian Pilarsky
Journal:  Oncogene       Date:  2005-07-28       Impact factor: 9.867

5.  Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation.

Authors:  Amjad Hussain; Clement Wesley; Mohammad Khalid; Ashutosh Chaudhry; Shahid Jameel
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

6.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

7.  The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity.

Authors:  Cécile Lemaître; Francis Harper; Gérard Pierron; Thierry Heidmann; Marie Dewannieux
Journal:  J Virol       Date:  2014-09-10       Impact factor: 5.103

8.  Identification of genes expressed in malignant cells that promote invasion.

Authors:  Jennifer Walter-Yohrling; Xiaohong Cao; Michele Callahan; William Weber; Sharon Morgenbesser; Stephen L Madden; Clarence Wang; Beverly A Teicher
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

9.  The Vpu-interacting Protein SGTA Regulates Expression of a Non-glycosylated Tetherin Species.

Authors:  Abdul A Waheed; Scott MacDonald; Maisha Khan; Megan Mounts; Maya Swiderski; Yue Xu; Yihong Ye; Eric O Freed
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

Review 10.  Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1.

Authors:  Greta Forlani; Mariam Shallak; Elise Ramia; Alessandra Tedeschi; Roberto S Accolla
Journal:  Retrovirology       Date:  2019-11-29       Impact factor: 4.602

View more
  2 in total

Review 1.  Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis.

Authors:  Nabab Khan; Jonathan D Geiger
Journal:  Viruses       Date:  2021-07-27       Impact factor: 5.048

Review 2.  Unravelling the Immunomodulatory Effects of Viral Ion Channels, towards the Treatment of Disease.

Authors:  Siobhan Gargan; Nigel J Stevenson
Journal:  Viruses       Date:  2021-10-27       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.